555 related articles for article (PubMed ID: 2053169)
1. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
Binkley LS
Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
[No Abstract] [Full Text] [Related]
2. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
Eschbach JW; Haley NR; Adamson JW
Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
[No Abstract] [Full Text] [Related]
3. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
von Appen K; Klinkmann H
Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
[No Abstract] [Full Text] [Related]
4. Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life.
Nissenson AR
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):25-31. PubMed ID: 2669083
[TBL] [Abstract][Full Text] [Related]
5. Advances in the management of chronic renal failure: the use of epoetin alfa in clinical practice. Proceedings of a symposium. June 6, 1989, Nashville, TN.
Pharmacotherapy; 1990; 10(2 ( Pt 2)):1S-26S. PubMed ID: 2345707
[No Abstract] [Full Text] [Related]
6. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
7. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
[No Abstract] [Full Text] [Related]
8. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
[TBL] [Abstract][Full Text] [Related]
9. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
Hussein MM; Mooij JM; Roujouleh H
Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
[No Abstract] [Full Text] [Related]
10. Erythropoietin therapy in patients with chronic renal failure.
Pinevich AJ; Petersen J
West J Med; 1992 Aug; 157(2):154-7. PubMed ID: 1441466
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on the improvement of quality of life with epoetin alfa therapy.
Lundin AP; Delano BG; Quinn-Cefaro R
Pharmacotherapy; 1990; 10(2 ( Pt 2)):22S-26S. PubMed ID: 2345708
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
Romero González R; Torquet Escuder P
Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
[No Abstract] [Full Text] [Related]
13. Recombinant erythropoietin for the anemia of chronic renal failure.
Ahmad R; Hand M
N Engl J Med; 1987 Jul; 317(3):169-70. PubMed ID: 3600706
[No Abstract] [Full Text] [Related]
14. Erythropoietin for anemia of renal failure in sickle cell disease.
Steinberg MH
N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
[No Abstract] [Full Text] [Related]
15. Review of patients' responses to epoetin alfa therapy.
Krantz SB
Pharmacotherapy; 1990; 10(2 ( Pt 2)):15S-21S. PubMed ID: 2189124
[TBL] [Abstract][Full Text] [Related]
16. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
Schaefer RM; Heidland A
Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
[No Abstract] [Full Text] [Related]
17. [Chronic kidney failure, anemia and erythropoietin].
Sulková S
Cas Lek Cesk; 1990 May; 129(18):545-9. PubMed ID: 2350772
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and therapy of renal anemia].
Hara S
Nihon Naika Gakkai Zasshi; 1999 Jun; 88(6):1029-34. PubMed ID: 10465946
[No Abstract] [Full Text] [Related]
19. Effects of erythropoietin on strength and functional status of patients on hemodialysis.
Guthrie M; Cardenas D; Eschbach JW; Haley NR; Robertson HT; Evans RW
Clin Nephrol; 1993 Feb; 39(2):97-102. PubMed ID: 8448925
[TBL] [Abstract][Full Text] [Related]
20. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
Nikolaev AIu; Klepikov PV; Lashutin SV
Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
